Mirimus is a biotechnology company specializing in preclinical research and drug discovery. They provide advanced animal models, 3D cell cultures, and RNAi therapeutics to researchers in the pharmaceutical and biotechnology sectors, enabling them to enhance the predictability of their research outcomes.
2010
51–200
